TI

Takayuki Iwai

Director Director DIN 06396363
DIN 06396363 First appointment Jan 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2013
Shareholding value Locked Premium profile

About Takayuki Iwai

Data last updated:

Takayuki Iwai has 13 years in corporate governance. Formerly with 1 company, such as Arch Pharmalabs Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06396363
Primary Designation Director
First Appointment 18 Jan 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Arch Pharmalabs Limited U24231MH1993PLC150891
Nominee Director18 Jan 20131993Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arch Pharmalabs Limited
Premium access

Shareholding and investment profile for Takayuki Iwai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Takayuki Iwai

Takayuki Iwai has 13 years in corporate governance. Formerly with 1 company, such as Arch Pharmalabs Limited. Engaged in General Business. Contributes to corporate operations.

Takayuki Iwai is associated with 0 companies as a director.

Takayuki Iwai has expertise in General Business.

Takayuki Iwai has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available